Wealth Advisory Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$316K Hold
2,117
– – 0.07% 114
2026
Q2
$267K Buy
2,117
+541
+34% +$71.3K 0.05% 123
2026
Q1
$220K Sell
1,576
-132
-8% -$18.5K 0.05% 132
2025
Q4
$210K Buy
+1,708
New +$208K 0.05% 135
2022
Q3
– Sell
-3,252
Closed -$201K – 139
2022
Q2
$201K Buy
+3,252
New +$201K 0.05% 141
2020
Q3
– Sell
-2,847
Closed -$219K – 182
2020
Q2
$219K Sell
2,847
-857
-23% -$65.7K 0.06% 167
2020
Q1
$276K Buy
3,704
+291
+9% +$20.1K 0.09% 135
2019
Q4
$221K Hold
3,413
– – 0.06% 168

Other funds holding GILD

Wealth Advisory Solutions's GILD Position: Q3 2026 in Review

Wealth Advisory Solutions held its Gilead Sciences (GILD) position steady in Q3 2026 at 2,117 shares worth $316K. The position accounts for 0.07% of the portfolio, ranked #114.

Wealth Advisory Solutions first reported a position in GILD in Q4 2019 and has held it in 8 quarters since. 2,354 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Wealth Advisory Solutions held 2,117 shares of Gilead Sciences worth $316K as of Q3 2026.
  • Wealth Advisory Solutions left its Gilead Sciences share count unchanged in Q3 2026.
  • Gilead Sciences made up 0.07% of Wealth Advisory Solutions's portfolio in Q3 2026, its #114 holding.
  • Wealth Advisory Solutions first reported a position in Gilead Sciences in Q4 2019 and has held it in 8 quarters since.
  • 2,354 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Wealth Advisory Solutions's 13F filing for Q3 2026, filed 20 Oct 2026.